To determine whether IgA–pIgR interactions elicit transcytosis through tumour cells, we first incubated pIgR+ OVCAR3 ovarian cancer cells with fluorescently labelled non-antigen-specific IgA or IgG (Fig. 2a, Extended Data Fig. 3b). Here, CD79A is linked to ovarian cancer.